Armata Pharmaceuticals (NYSEMKT:ARMP) just reported results for the first quarter of 2024.
- Armata Pharmaceuticals reported earnings per share of -69 cents. This was below the analyst estimate for EPS of -31 cents.
- The company reported revenue of $966,000.
- This was 12.18% worse than the analyst estimate for revenue of $1.10 million.